33 Multidrug-Resistant Gram Negative Bacteria

Saturday, April 2, 2011: 1:00 PM-2:15 PM
Trinity Ballroom (Hilton Anatole)
Type: Abstracts
271
Growing Prevalence of Providencia stuartii at Detroit Medical Center, 2005-2009
Kayoko Hayakawa, MD, PhD, Detroit Medical Center, Wayne State University; Jason M. Pogue, PharmD, Detroit Medical Center, Wayne State University; Paul R. Lephart, PhD, Detroit Medical Center, Wayne State University; Sarwan Kumar, MD, Detroit Medical Center, Wayne State University; Ryan P. Mynatt, PharmD, Detroit Medical Center, Wayne State University; Jing J. Zhao, PharmD, Detroit Medical Center, Wayne State University; Teena Chopra, MD, Detroit Medical Center, Wayne State University; Sorabh Dhar, MD, Detroit Medical Center, Wayne State University; Jack D. Sobel, MD, Detroit Medical Center, Wayne State University; Keith S. Kaye, MD, MPH, Detroit Medical Center, Wayne State University; Dror Marchaim, MD, Detroit Medical Center, Wayne State University
272
Reduction in MDRA Transmission in an Adult ICU via a Multifaceted Approach Including Universal Gown and Gloves
Jay Hawkshead, DrPH, Cand, Touro Infirmary; Joann Bowles, RN, Touro Infirmary; Julio Figueroa, MD, Touro Infirmary
273
Multidrug-Resistant Gram-Negative Bacteria within a Long-Term Acute Care Hospital: a Review of Five Years of Clinical Cultures
Erin O'Fallon, MD, Hebrew Senior Life Institute for Aging Research; Teresa Fung, Pharm, D, Hebrew Senior Life Institute for Aging Research; Jonathan Carlson, MD, PhD, Dana Farber Cancer Institute; Erika D'Agata, MD, MPH, Beth Israel Deaconess Medical Center
274
Investigation of a Pan-Resistant Verona Integron-Encoded Metallo-Beta-Lactamase-Producing Klebsiella pneumoniae
Neil Gupta, MD, Centers for Disease Control and Prevention; Susan N. Hocevar, MD, Centers for Disease Control and Prevention; Anthony A. Marfin, MD, MPH, MA, Washington State Dept. of Health; Karen F. Anderson, BS, MT(ASCP), Centers for Disease Control and Prevention; Nancye C. Clark, MS, Centers for Disease Control and Prevention; Duncan R. MacCannell, PhD, Centers for Disease Control and Prevention; James K. Rasheed, PhD, Centers for Disease Control and Prevention; Carolyn V. Gould, MD, MSCR, Centers for Disease Control and Prevention; Brandi M. Limbago, PhD, Centers for Disease Control and Prevention; Alexander J. Kallen, MD, MPH, Centers for Disease Control and Prevention
275
Epidemiology of Non-Bloodstream Sterile-Site Infections due to Extended Spectrum -Lactamase-producing organisms (ESBLs) within a Detroit Health System
Ylinne Lynch, BS, Detroit Medical Center, Wayne State University; Heather Bowman, BS, Detroit Medical Center, Wayne State University; Jennifer Veltman, MD, Detroit Medical Center, Wayne State University; Ryan Tansek, BS, Detroit Medical Center, Wayne State University; Palaniappan Manickam, MD, MPH, Detroit Medical Center, Wayne State University; Odaliz Abreulanfranco, MD, Detroit Medical Center, Wayne State University; Dror Marchaim, MD, Detroit Medical Center, Wayne State University; Kayoko Hayakawa, MD, PhD, Detroit Medical Center, Wayne State University; Sorabh Dhar, MD, Detroit Medical Center, Wayne State University; Jing Zhao, PharmD, Detroit Medical Center, Wayne State University; Jason M. Pogue, Pharm, D, Detroit Medical Center, Wayne State University; Paul Lephart, Detroit Medical Center, Wayne State University; George Alangaden, MD, Detroit Medical Center, Wayne State University; Keith S. Kaye, MD, MPH, Detroit Medical Center, Wayne State University; Teena Chopra, MD, Detroit Medical Center, Wayne State University
276
Characteristics and Outcomes of Patients Treated with Intravenous Colistin for Multidrug-Resistant Gram-Negative Bacterial Infections
Monica Sharma, DO, Indiana University Medical Center; Mitchell Goldman, MD, Indiana University Medical Center; Sharon M. Erdman, PharmD, Wishard Memorial Hospital; Suellyn J. Sorensen, PharmD, Indiana University Medical Center; Stephen J. Wilson, MD, MPH, New York Presbyterian Weill Cornell Medical Center
277
Colistin versus tigecycline for the treatment of Acinetobacter baumannii and/or carbapenem resistant Enterobacteriaceae infections
Kimberley Ku, BS, Detroit Medical Center, Wayne State University; Judy Moshos, MT, Detroit Medical Center, Wayne State University; Suchitha Bheemreddy, MD, Detroit Medical Center, Wayne State University; Yujing Wang, BS, Detroit Medical Center, Wayne State University; Ashish Bhargava, Detroit Medical Center, Wayne State University; Michelle Campbell, BA, Detroit Medical Center, Wayne State University; Namir Khandker, BS, Detroit Medical Center, Wayne State University; Teena Chopra, MD, Detroit Medical Center, Wayne State University; Kayoko Hayakawa, MD, PhD, Detroit Medical Center, Wayne State University; Odaliz Abreulanfranco, MD, Detroit Medical Center,Wayne State University; Paul R. Lephart, PhD, Detroit Medical Center, Wayne State University; Jason M. Pogue, PharmD, Detroit Medical Center, Wayne State University; Sorabh Dhar, MD, Detroit Medical Center, Wayne State University; Keith S. Kaye, MD, MPH, Detroit Medical Center, Wayne State University; Dror Marchaim, MD, Detroit Medical Center, Wayne State University
278
Epidemiology of KPC-Producing Enterobacteriaceae in a Chicago Hospital
Shirley Shores, MA, Northwestern Memorial Hospital; Maureen K. Bolon, MD, MS, Northwestern University; Sandra Reiner, RN, BSN, Northwestern Memorial Hospital; Jean A. Patel, PharmD, Northwestern Memorial Hospital; Michael J. Postelnick, RPh, BCPS, AQ, ID, Northwestern Memorial Hospital; Michael Malczynski, BA, Northwestern Memorial Hospital; Chao Qi, PhD, Northwestern University; Teresa Zembower, MD, MPH, Northwestern University
279
A Horizontal Approach for Reducing Acinetobacter Device Associated Infections
Heather L. Albert, RN, BSN, Virginia Commonwealth University Medical Center; Diane E. Heipel, RN, BSN, Virginia Commonwealth University Medical Center; Connie Atkinson, RN, Virginia Commonwealth University Medical Center; Kakotan Sanogo, Virginia Commonwealth University Medical Center; Janis Ober, Virginia Commonwealth University Medical Center; Gonzalo Bearman, MD, MPH, Virginia Commonwealth University Medical Center; Michael P. Stevens, MD, Virginia Commonwealth University Medical Center; Michael B. Edmond, MD, MPH, MPA, Virginia Commonwealth University Medical Center
280
Predictors and outcomes of patients with carbapenem-resistant Enterobacteriaceae co-colonized with Acinetobacter baumannii or Pseudomonas aeruginosa
Dror Marchaim, MD, Detroit Medical Center, Wayne State University; Federico Perez, Cleveland VA Medical Center; Kayoko Hayakawa, MD, PhD, Detroit Medical Center, Wayne State University; Palaniappan Manickam, MD, MPH, Detroit Medical Center, Wayne State University; Paul R. Lephart, PhD, Detroit Medical Center, Wayne State University; Suchitha Bheemreddy, MD, Detroit Medical Center, Wayne State University; Bharath Sunkara, MD, Detroit Medical Center, Wayne State University; Christopher Blunden, BS, Detroit Medical Center,Wayne State University; Andrea M. Hujer, BA, Research Service, Louis Stokes Cleveland Department of Veterans Affairs Medical Center,; Susan Rudin, BA, Louis Stokes Cleveland VA Medical Center; Maryann Shango, BS, Detroit Medical Center, Wayne State University; Michelle Campbell, BA, Detroit Medical Center, Wayne State University; Jastin Varkey, BA, Detroit Medical Center, Wayne State University; Diixa Patel, MD, Detroit Medical Center, Wayne State University; Teena Chopra, MD, Detroit Medical Center, Wayne State University; Jason M. Pogue, PharmD, Detroit Medical Center, Wayne State University; Sorabh Dhar, MD, Detroit Medical Center, Wayne State University; Robert A. Bonomo, MD, Louis Stokes Cleveland VA Medical Center; Keith S. Kaye, MD, MPH, Detroit Medical Center, Wayne State University
281
Clinical Outcomes of Septic Patients with Carbapenemase Producing Klebsiella pneumoniae at a New York City Hospital
Jacques Simkins, MD, Montefiore Medical Center of Albert Einstein College of Medicine; Negia Elisa Lalane, MD, Jacobi Medical Center, Albert Einstein College of Medicine; Sharon Leung, MD, Montefiore Medical Center of Albert Einstein College of Medicine; Reha Pokharel, MD, Montefiore Medical Center of Albert Einstein College of Medicine; Brian P. Currie, MD, MPH, Montefiore Medical Center of Albert Einstein College of Medicine
282
Carbapenem Resistant Enterobacteriaceae: Risk Factors and Role of Extended Care Facilities
Andres O. Makarem, MD, Advocate Illinois Masonic Medical Center; Paola I. Alvarez, MD, Advocate Illinois Masonic Medical Center; Teresa Chou, MPH, CIC, Advocate Illinois Masonic Medical Center; Mandavi Kulkarni, MD, Advocate Illinois Masonic Medical Center; James Kerridge, MA, RN, CIC, Advocate Illinois Masonic Medical Center; Wickman Katie, MS, RN, Advocate Illinois Masonic Medical Center; Michael Costello, PhD, ACL Laboratories; James Malow, MD, FIDSA, Advocate Illinois Masonic Medical Center
283
Comparative Effectiveness of Tigecycline, Polymyxin B, and Aminoglycosides in Eradicating Carbapenem-resistant Klebsiella pneumoniae (CRKP) from the Urine
Michael J. Satlin, MD, Weill Cornell Medical College; Christine J. Kubin, PharmD, BCPS, Columbia University; NewYork-Presbyterian Hospital; Jill S. Blumenthal, MD, New York-Presbyterian Hospital/Weill Cornell Medical Center; Andrew B. Cohen, MD, New York-Presbyterian Hospital/Weill Cornell Medical Center; E. Yoko Furuya, MD, MS, Columbia University; Stephen J. Wilson, MD, MPH, Weill Cornell Medical College; Stephen G. Jenkins, PhD, Weill Cornell Medical College; David P. Calfee, MD, MS, Weill Cornell Medical College
284
Admission Screening for ESBL-producing Enterobacteriaceae (ESBL-E): Impact on Nosocomial Transmission Over a 6 Year Period
Christopher Fong Jen Lowe, MD, University of Toronto; Kevin C. Katz, MD, North York General Hospital; Matthew Paul Muller, MD, PhD, FRCPC, St Michael's Hospital; Allison McGeer, MD, FRCP, Mount Sinai Hospital
285
Epidemiology and Risk Factors of Patients with Blood Stream Infection (BSI) due to Acinetobacter baumannii (AB) A Multicenter Case-Control Study
Teena Chopra, MD, Detroit Medical Center, Wayne State University; Paul C. Johnson, MD, Detroit Medical Center, Wayne State University; Hardik Doshi, MBBS, Detroit Medical Center, Wayne State University; Jing J. Zhao, PharmD, Detroit Medical Center, Wayne State University; Jason M. Pogue, PharmD, Detroit Medical Center, Wayne State University; Kayoko Hayakawa, MD, PhD, Detroit Medical Center, Wayne State University; Odaliz Abreu-Lanfranco, MD, Detroit Medical Center, Wayne State University; Sapna Parmar, Detroit Medical Center, Wayne State University; Dror Marchaim, MD, Detroit Medical Center, Wayne State University; Sorabh Dhar, MD, Detroit Medical Center, Wayne State University; Keith S. Kaye, MD, MPH, Detroit Medical Center, Wayne State University
286
Risk Factors Associated with Extended-Spectrum β-Lactamase (ESBL) Blood Stream Infection (BSI)
Teena Chopra, MD, Detroit Medical Center, Wayne State University; Paul C. Johnson, MD, Detroit Medical Center, Wayne State University; Indu Chalana, MD, Detroit Medical Center, Wayne State University; Sanjeev Patil, MD, Detroit Medical Center, Wayne State University; Zeinab Tamam, MD, Detroit Medical Center, Wayne State University; Mazin Mohammed, BS, Detroit Medical Center, Wayne State University; Shatha Alkatib, MD, Detroit Medical Center, Wayne State University; Ryan Tansek, BS, Detroit Medical Center, Wayne State University; Khawar Chaudhry, BS, Detroit Medical Center, Wayne State University; Dror Marchaim, MD, Detroit Medical Center, Wayne State University; Jing J. Zhao, PharmD, Detroit Medical Center, Wayne State University; Jason M. Pogue, PharmD, Detroit Medical Center, Wayne State University; Sorabh Dhar, MD, Detroit Medical Center, Wayne State University; Keith S. Kaye, MD, MPH, Detroit Medical Center, Wayne State University
287
Search and Destroy: A bundle Intervention for the Control of Carbapenem-Resistant Acinetobacter baumannii (CRAB) outbreaks
L. Silvia Munoz-Price, MD, University of Miami; Gabriel Coro, RN, Jackson Memorial Hospital; Timothy Cleary, PhD, University of Miami; Madelaine Tamayo, RN, Jackson Memorial Hospital; Amos Adedokum, RN, Jackson Memorial Hospital; Lisa Francois, RN, Jackson Memorial Hospital; Regina McDade, EdD, RN, Jackson Memorial Hospital; Maria Socarras, RN, Jackson Memorial Hospital; Stephen Adams, RN, Jackson Memorial Hospital; Laurent Poirel, PhD, Hopital de Bicetre
288
Impact of consolidative antimicrobial therapy on mortality in patients with blood stream infections (BSIs) due to extended spectrum β-lactamase-producing pathogens
Jennifer Veltman, MD, Wayne State University, Detroit Medical Center, Detroit, MI; Jing Zhao, Pharm, D, Detroit Medical Center,Wayne State University; Ryan Tansek, BS, Wayne State University; Dania Hatahet, MD, Detroit Medical Center,Wayne State University; Khawar Chaudry, BS, Detroit Medical Center, Wayne State University; Jason M. Pogue, Pharm, D, Detroit Medical Center, Wayne State University; Ashish Bhargava, Detroit Medical Center, Wayne State University; Ylinne Lynch, BS, Wayne State University; Dror Marchaim, MD, Detroit Medical Center, Wayne State University; George Alangaden, MD, Detroit Medical Center,Wayne State University; Keith S. Kaye, MD, MPH, Detroit Medical Center, Wayne State University; Teena Chopra, MD, Detroit Medical Center, Wayne State University
289
New Delhi Metallo-Beta-Lactamases -1 in a tertiary care pediatric center
Vikas Manchanda, MBBS, MD, Chacha Nehru Bal Chikitsalaya; Nalini Singh, MD, Children's National Medical Center; Nishant Verma, MD, Chacha Nehru Bal Chikitsalaya; Rajan Chopra, MBBS, MD, Chacha Nehru Bal Chikitsalaya
290
Risk of acquiring Extended-spectrum-Beta-lactamase (ESBL) producing Klebsiella pneumoniae and Escherichia coli from prior room occupants in the intensive care unit
Adebola Ajao, MPH, University of Maryland; J. Kristie Johnson, PhD, University of Maryland; Anthony D. Harris, MD, MS, University of Maryland; Min Zhan, PhD, University of Maryland; Jessina C. McGregor, PhD, Oregon State University College of Pharmacy; Kerri A. Thom, MD, MS, University of Maryland; Jon P. Furuno, PhD, University of Maryland